2007
DOI: 10.1016/j.jhazmat.2007.07.008
|View full text |Cite
|
Sign up to set email alerts
|

Effluent from drug manufactures contains extremely high levels of pharmaceuticals

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

16
612
1
24

Year Published

2010
2010
2022
2022

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 1,288 publications
(653 citation statements)
references
References 26 publications
16
612
1
24
Order By: Relevance
“…Other example of an anthropogenic activity is aquaculture, whose pharmaceuticals employed, as well as their metabolites and degradation prod-ucts, are directly discharged into surface waters [45,46]. Another important source of environmental contamination by pharma-ceuticals is the effluents of pharmaceutical production facilities [47][48][49].…”
Section: Sources Of Environmental Contaminationmentioning
confidence: 99%
See 1 more Smart Citation
“…Other example of an anthropogenic activity is aquaculture, whose pharmaceuticals employed, as well as their metabolites and degradation prod-ucts, are directly discharged into surface waters [45,46]. Another important source of environmental contamination by pharma-ceuticals is the effluents of pharmaceutical production facilities [47][48][49].…”
Section: Sources Of Environmental Contaminationmentioning
confidence: 99%
“…CO2 and water); (ii) entrapment by suspended solids; (iii) discharge of the parent compound through chemical cleavage of the respective con-jugate forms and (iv) conversion to a more hydrophilic, persistent form which will short-circuit the treatment process [39,41,56,57]. Thus, in hospitals use of specific antibiotics, antineoplasic or diag-nostic agents subsequently requires a sewage treatment process more embracing and directed to these kind of drugs, which are only used in hospitals [35,58], and that must be different to the more specific procedure adopted at STPs receiving industrial discharges from drug manufactures [47][48][49]59]. In both, the form and extension of the final contamination risk will also depend on geographical location of the STP facility.…”
Section: Environmental Fatementioning
confidence: 99%
“…There are a large number of studies of WTW effluent and septic tanks (Clara et al, 2004;Drewes et al, 2003;Gasser et al, 2010;Glassmeyer et al, 2008;Heberer et al, 1997;Kreuzinger et al, 2004), of raw sewage (Sodré et al, 2009) and of artificial recharge using treated effluent (Cordy et al, 2004;Díaz-Cruz and Barceló, 2008). Manufacturing sites may also contribute (Larsson, 2008;Larsson et al, 2007). There are about 9000 WTWs in the UK serving 95% of the population (Water UK, 2006).…”
Section: Source Termsmentioning
confidence: 99%
“…Industrial pharmaceutical wastewater treatment plants without effective treatment of antibiotics have become a significant threat for aquatic environment (Larsson, 2007).…”
Section: Introductionmentioning
confidence: 99%